Cargando…

Evaluation of Pharmacogenetics of Drug-Metabolizing Enzymes and Drug Efflux Transporter in Renal Transplants Receiving Immunosuppressants

Cytochrome P450 (CYP) enzymes, such as CYP3A4, and CYP3A5, P450 oxidoreductase (POR), peroxisome proliferator activated receptor alpha (PPAR-alpha), and drug transporter (ABCB1) were observed to influence concentrations of immunosuppressants (cyclosporine, everolimus, sirolimus, and tacrolimus) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sridharan, Kannan, Shah, Shamik, Jassim, Anfal, Hammad, Mona, Ebrahim Al Gadhban, Johaina, Al Segai, Ola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147030/ https://www.ncbi.nlm.nih.gov/pubmed/35629245 http://dx.doi.org/10.3390/jpm12050823

Ejemplares similares

Evaluation of Genetic Polymorphisms of the Antioxidant Enzymes and Biomarkers of Oxidative Stress in Preterm Neonates With Respiratory Distress Syndrome Receiving External Surfactant
por: Sridharan, Kannan, et al.
Publicado: (2022)

Evaluation of the Association between Single Nucleotide Polymorphisms of Metabolizing Enzymes with the Serum Concentration of Paracetamol and Its Metabolites
por: Sridharan, Kannan, et al.
Publicado: (2022)

Pharmacogenetics of immunosuppressant drugs: A new aspect for individualized therapy
por: Salvadori, Maurizio, et al.
Publicado: (2020)

Pharmacogenetics of analgesic drugs
por: Cregg, Roman, et al.
Publicado: (2013)

Pharmacogenetics of Antiplatelet Drugs
por: Curtin, Ronan, et al.
Publicado: (2002)

Pharmacogenetic And Tumour Drugs
por: Topic, Elizabeta
Publicado: (2005)

Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
por: Iannaccone, Teresa, et al.
Publicado: (2021)

Pharmacogenetics of Anti-Diabetes Drugs
por: DiStefano, Johanna K., et al.
Publicado: (2010)

Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013)

Pharmacogenetics and outcome with antipsychotic drugs
por: Pouget, Jennie G., et al.
Publicado: (2014)

7. Pharmacogenetics of Drug Receptors
por: Marc, Janja
Publicado: (2008)

Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics
por: Adhikari, Archana, et al.
Publicado: (2021)

Drugs impact on CYP-450 enzyme family: A pharmacogenetical study of response variation
por: Kalra, Kapil, et al.
Publicado: (2009)

The Pharmacogenetics of Symptom Response to Antipsychotic Drugs
por: Reynolds, Gavin P
Publicado: (2012)

Pharmacogenetic information for patients on drug labels
por: Haga, Susanne B, et al.
Publicado: (2014)

Genetics of Psoriasis and Pharmacogenetics of Biological Drugs
por: Prieto-Pérez, Rocío, et al.
Publicado: (2013)

Use of Pharmacogenetic Drugs by the Dutch Population
por: Alshabeeb, Mohammad A., et al.
Publicado: (2019)

Pharmacogenetics of new classes of antidiabetic drugs
por: Kadrić, Selma Imamović, et al.
Publicado: (2021)

Pharmacogenetics of Drugs Used in the Treatment of Cancers
por: Franczyk, Beata, et al.
Publicado: (2022)

Pharmacogenetics to Avoid Adverse Drug Reactions
por: López-Fernández, Luis A.
Publicado: (2022)

Pharmacogenetics of novel glucose-lowering drugs
por: Rathmann, Wolfgang, et al.
Publicado: (2021)

Drug-Induced Liver Injury in Critically Ill Children Taking Antiepileptic Drugs: A Retrospective Study
por: Sridharan, Kannan, et al.
Publicado: (2020)

Individualized immunosuppression in transplant patients: potential role of pharmacogenetics
por: Abboudi, Hamid, et al.
Publicado: (2012)

Pharmacogenetic Study of Drug-Metabolising Enzyme Polymorphisms on the Risk of Anti-Tuberculosis Drug-Induced Liver Injury: A Meta-Analysis
por: Cai, Yu, et al.
Publicado: (2012)

Pharmacogenetics of anticancer drugs in non-Hodgkin lymphomas
por: Loni, L, et al.
Publicado: (2001)

Pharmacogenetics and anaesthetic drugs: Implications for perioperative practice
por: Behrooz, Arash
Publicado: (2015)

Pharmacogenetics and Predictive Testing of Drug Hypersensitivity Reactions
por: Böhm, Ruwen, et al.
Publicado: (2016)

Pharmacogenetics of antiepileptic drugs: A brief review
por: Parker, D., et al.
Publicado: (2016)

Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)
por: Smolarz, Beata, et al.
Publicado: (2021)

Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment
por: Brockmöller, Jürgen, et al.
Publicado: (2008)

Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery
por: Sim, E, et al.
Publicado: (2014)

Importance of Pharmacogenetics and Drug–Drug Interactions in a Kidney Transplanted Patient
por: Concha, Julia, et al.
Publicado: (2023)

Immunosuppressive Drugs
por: Hussain, Yaseen, et al.
Publicado: (2022)

Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
por: Urzì Brancati, Valentina, et al.
Publicado: (2022)

Atrial fibrillation gut syndrome: severe gastroparesis with pyloric spasm following radiofrequency catheter ablation of drug resistant symptomatic atrial fibrillation: a case report
por: Kannan, Lakshmi, et al.
Publicado: (2023)

Tepotinib Inhibits Several Drug Efflux Transporters and Biotransformation Enzymes: The Role in Drug-Drug Interactions and Targeting Cytostatic Resistance In Vitro and Ex Vivo
por: Vagiannis, Dimitrios, et al.
Publicado: (2021)

The role of efflux transporters and metabolizing enzymes in brain and peripheral organs to explain drug‐resistant epilepsy
por: Vázquez, Marta, et al.
Publicado: (2021)

Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics
por: Perwitasari, D. A., et al.
Publicado: (2011)

Pharmacogenetics of Parkinson’s Disease – Through Mechanisms of Drug Actions
por: Droździk, Marek, et al.
Publicado: (2013)

Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients
por: Zununi Vahed, Sepideh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o1rvicmddf7nkiihqk05glm9fo